nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—KCNJ11—epilepsy syndrome	0.434	1	CbGaD
Glimepiride—CYP2C9—Trimethadione—epilepsy syndrome	0.0386	0.17	CbGbCtD
Glimepiride—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0363	0.16	CbGbCtD
Glimepiride—CYP2C9—Carbamazepine—epilepsy syndrome	0.0261	0.115	CbGbCtD
Glimepiride—CYP2C9—Primidone—epilepsy syndrome	0.0243	0.107	CbGbCtD
Glimepiride—CYP2C9—Phenytoin—epilepsy syndrome	0.0234	0.103	CbGbCtD
Glimepiride—CYP2C9—Propofol—epilepsy syndrome	0.0218	0.0962	CbGbCtD
Glimepiride—CYP2C9—Phenobarbital—epilepsy syndrome	0.0208	0.0919	CbGbCtD
Glimepiride—CYP2C9—Diazepam—epilepsy syndrome	0.0197	0.0872	CbGbCtD
Glimepiride—CYP2C9—Valproic Acid—epilepsy syndrome	0.0156	0.0687	CbGbCtD
Glimepiride—KCNJ1—forebrain—epilepsy syndrome	0.00195	0.103	CbGeAlD
Glimepiride—KCNJ1—telencephalon—epilepsy syndrome	0.00179	0.0944	CbGeAlD
Glimepiride—ABCC8—brainstem—epilepsy syndrome	0.00113	0.0594	CbGeAlD
Glimepiride—KCNJ1—head—epilepsy syndrome	0.00112	0.0588	CbGeAlD
Glimepiride—ABCC8—forebrain—epilepsy syndrome	0.00109	0.0573	CbGeAlD
Glimepiride—KCNJ1—nervous system—epilepsy syndrome	0.00106	0.0557	CbGeAlD
Glimepiride—KCNJ1—central nervous system—epilepsy syndrome	0.00102	0.0536	CbGeAlD
Glimepiride—ABCC8—telencephalon—epilepsy syndrome	0.001	0.0527	CbGeAlD
Glimepiride—KCNJ1—brain—epilepsy syndrome	0.000808	0.0426	CbGeAlD
Glimepiride—ABCC8—medulla oblongata—epilepsy syndrome	0.000786	0.0414	CbGeAlD
Glimepiride—Gliquidone—KCNJ11—epilepsy syndrome	0.000779	0.15	CrCbGaD
Glimepiride—ABCC8—midbrain—epilepsy syndrome	0.000718	0.0379	CbGeAlD
Glimepiride—ABCC8—spinal cord—epilepsy syndrome	0.000701	0.0369	CbGeAlD
Glimepiride—KCNJ11—head—epilepsy syndrome	0.000676	0.0356	CbGeAlD
Glimepiride—KCNJ11—nervous system—epilepsy syndrome	0.000641	0.0338	CbGeAlD
Glimepiride—ABCC8—head—epilepsy syndrome	0.000623	0.0328	CbGeAlD
Glimepiride—KCNJ11—central nervous system—epilepsy syndrome	0.000617	0.0325	CbGeAlD
Glimepiride—KCNJ11—cerebellum—epilepsy syndrome	0.000603	0.0318	CbGeAlD
Glimepiride—ABCC8—nervous system—epilepsy syndrome	0.000591	0.0311	CbGeAlD
Glimepiride—ABCC8—central nervous system—epilepsy syndrome	0.000569	0.03	CbGeAlD
Glimepiride—Glisoxepide—KCNJ11—epilepsy syndrome	0.000563	0.108	CrCbGaD
Glimepiride—ABCC8—cerebellum—epilepsy syndrome	0.000556	0.0293	CbGeAlD
Glimepiride—KCNJ11—brain—epilepsy syndrome	0.00049	0.0258	CbGeAlD
Glimepiride—Glipizide—KCNJ11—epilepsy syndrome	0.000481	0.0925	CrCbGaD
Glimepiride—ABCC8—brain—epilepsy syndrome	0.000451	0.0238	CbGeAlD
Glimepiride—Gliclazide—KCNJ11—epilepsy syndrome	0.000447	0.086	CrCbGaD
Glimepiride—Tolbutamide—SLCO1A2—epilepsy syndrome	0.000383	0.0737	CrCbGaD
Glimepiride—Chlorpropamide—KCNJ11—epilepsy syndrome	0.000348	0.0669	CrCbGaD
Glimepiride—Gliclazide—VEGFA—epilepsy syndrome	0.000347	0.0667	CrCbGaD
Glimepiride—Tolbutamide—KCNJ11—epilepsy syndrome	0.000339	0.0652	CrCbGaD
Glimepiride—Glyburide—SLCO1A2—epilepsy syndrome	0.000266	0.0511	CrCbGaD
Glimepiride—Glyburide—KCNJ11—epilepsy syndrome	0.000235	0.0452	CrCbGaD
Glimepiride—Gliclazide—CYP2C19—epilepsy syndrome	0.000168	0.0323	CrCbGaD
Glimepiride—Chlorpropamide—CYP2C19—epilepsy syndrome	0.000131	0.0251	CrCbGaD
Glimepiride—Tolbutamide—CYP2C19—epilepsy syndrome	0.000127	0.0245	CrCbGaD
Glimepiride—Glyburide—ABCC2—epilepsy syndrome	0.000127	0.0244	CrCbGaD
Glimepiride—Glyburide—ABCG2—epilepsy syndrome	0.000112	0.0216	CrCbGaD
Glimepiride—Gliclazide—ALB—epilepsy syndrome	9.32e-05	0.0179	CrCbGaD
Glimepiride—Glyburide—CYP2C19—epilepsy syndrome	8.83e-05	0.017	CrCbGaD
Glimepiride—ABCC8—Neuronal System—CHRNA4—epilepsy syndrome	8.16e-05	0.000722	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—APOD—epilepsy syndrome	8.13e-05	0.000719	CbGpPWpGaD
Glimepiride—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	8.08e-05	0.000715	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—PRKCB—epilepsy syndrome	7.99e-05	0.000707	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	7.92e-05	0.000701	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	7.92e-05	0.000701	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CHRNA4—epilepsy syndrome	7.91e-05	0.0007	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	7.7e-05	0.000682	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	7.69e-05	0.00068	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	7.63e-05	0.000676	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	7.59e-05	0.000671	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	7.56e-05	0.000669	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	7.53e-05	0.000667	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	7.49e-05	0.000663	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	7.24e-05	0.000641	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	7.24e-05	0.000641	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	7.24e-05	0.000641	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	7.24e-05	0.000641	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—BCHE—epilepsy syndrome	7.19e-05	0.000637	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—DLG4—epilepsy syndrome	7.02e-05	0.000621	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—BCHE—epilepsy syndrome	6.98e-05	0.000617	CbGpPWpGaD
Glimepiride—Chlorpropamide—ABCB1—epilepsy syndrome	6.92e-05	0.0133	CrCbGaD
Glimepiride—ABCC8—Neuronal System—GRIN2B—epilepsy syndrome	6.86e-05	0.000607	CbGpPWpGaD
Glimepiride—Dry mouth—Valproic Acid—epilepsy syndrome	6.86e-05	0.00034	CcSEcCtD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	6.85e-05	0.000606	CbGpPWpGaD
Glimepiride—Agitation—Pregabalin—epilepsy syndrome	6.84e-05	0.000339	CcSEcCtD
Glimepiride—Headache—Levetiracetam—epilepsy syndrome	6.84e-05	0.000339	CcSEcCtD
Glimepiride—Erythema—Gabapentin—epilepsy syndrome	6.83e-05	0.000338	CcSEcCtD
Glimepiride—Malnutrition—Gabapentin—epilepsy syndrome	6.83e-05	0.000338	CcSEcCtD
Glimepiride—KCNJ11—Neuronal System—DLG4—epilepsy syndrome	6.81e-05	0.000602	CbGpPWpGaD
Glimepiride—Angioedema—Pregabalin—epilepsy syndrome	6.81e-05	0.000337	CcSEcCtD
Glimepiride—Hypersensitivity—Clonazepam—epilepsy syndrome	6.8e-05	0.000337	CcSEcCtD
Glimepiride—Dizziness—Vigabatrin—epilepsy syndrome	6.79e-05	0.000336	CcSEcCtD
Glimepiride—ABCC8—Neuronal System—PLCB1—epilepsy syndrome	6.79e-05	0.000601	CbGpPWpGaD
Glimepiride—Confusional state—Valproic Acid—epilepsy syndrome	6.78e-05	0.000336	CcSEcCtD
Glimepiride—Pruritus—Zonisamide—epilepsy syndrome	6.78e-05	0.000336	CcSEcCtD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	6.76e-05	0.000598	CbGpPWpGaD
Glimepiride—Hypersensitivity—Phenytoin—epilepsy syndrome	6.76e-05	0.000335	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	6.73e-05	0.000596	CbGpPWpGaD
Glimepiride—Anaphylactic shock—Valproic Acid—epilepsy syndrome	6.72e-05	0.000333	CcSEcCtD
Glimepiride—Urticaria—Lamotrigine—epilepsy syndrome	6.72e-05	0.000333	CcSEcCtD
Glimepiride—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.72e-05	0.000333	CcSEcCtD
Glimepiride—Bradycardia—Topiramate—epilepsy syndrome	6.72e-05	0.000333	CcSEcCtD
Glimepiride—Nausea—Propofol—epilepsy syndrome	6.71e-05	0.000332	CcSEcCtD
Glimepiride—Tension—Gabapentin—epilepsy syndrome	6.7e-05	0.000332	CcSEcCtD
Glimepiride—Vomiting—Fosphenytoin—epilepsy syndrome	6.7e-05	0.000332	CcSEcCtD
Glimepiride—Diarrhoea—Felbamate—epilepsy syndrome	6.7e-05	0.000332	CcSEcCtD
Glimepiride—Abdominal pain—Lamotrigine—epilepsy syndrome	6.69e-05	0.000331	CcSEcCtD
Glimepiride—Dizziness—Diazepam—epilepsy syndrome	6.69e-05	0.000331	CcSEcCtD
Glimepiride—Leukopenia—Pregabalin—epilepsy syndrome	6.67e-05	0.00033	CcSEcCtD
Glimepiride—KCNJ11—Neuronal System—GRIN2B—epilepsy syndrome	6.65e-05	0.000589	CbGpPWpGaD
Glimepiride—Rash—Fosphenytoin—epilepsy syndrome	6.64e-05	0.000329	CcSEcCtD
Glimepiride—Dermatitis—Fosphenytoin—epilepsy syndrome	6.64e-05	0.000329	CcSEcCtD
Glimepiride—Nervousness—Gabapentin—epilepsy syndrome	6.63e-05	0.000329	CcSEcCtD
Glimepiride—Asthenia—Clonazepam—epilepsy syndrome	6.63e-05	0.000328	CcSEcCtD
Glimepiride—Headache—Fosphenytoin—epilepsy syndrome	6.6e-05	0.000327	CcSEcCtD
Glimepiride—Hepatitis—Topiramate—epilepsy syndrome	6.6e-05	0.000327	CcSEcCtD
Glimepiride—Thrombocytopenia—Valproic Acid—epilepsy syndrome	6.58e-05	0.000326	CcSEcCtD
Glimepiride—Palpitations—Pregabalin—epilepsy syndrome	6.58e-05	0.000326	CcSEcCtD
Glimepiride—KCNJ11—Neuronal System—PLCB1—epilepsy syndrome	6.58e-05	0.000582	CbGpPWpGaD
Glimepiride—Asthenia—Phenytoin—epilepsy syndrome	6.58e-05	0.000326	CcSEcCtD
Glimepiride—Nausea—Midazolam—epilepsy syndrome	6.57e-05	0.000325	CcSEcCtD
Glimepiride—Tachycardia—Valproic Acid—epilepsy syndrome	6.56e-05	0.000325	CcSEcCtD
Glimepiride—Diarrhoea—Zonisamide—epilepsy syndrome	6.56e-05	0.000325	CcSEcCtD
Glimepiride—Loss of consciousness—Pregabalin—epilepsy syndrome	6.55e-05	0.000324	CcSEcCtD
Glimepiride—Asthenia—Oxcarbazepine—epilepsy syndrome	6.55e-05	0.000324	CcSEcCtD
Glimepiride—Pruritus—Clonazepam—epilepsy syndrome	6.53e-05	0.000324	CcSEcCtD
Glimepiride—Vomiting—Vigabatrin—epilepsy syndrome	6.53e-05	0.000323	CcSEcCtD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	6.53e-05	0.000578	CbGpPWpGaD
Glimepiride—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.5e-05	0.000322	CcSEcCtD
Glimepiride—Pruritus—Phenytoin—epilepsy syndrome	6.49e-05	0.000321	CcSEcCtD
Glimepiride—Nausea—Levetiracetam—epilepsy syndrome	6.49e-05	0.000321	CcSEcCtD
Glimepiride—Rash—Vigabatrin—epilepsy syndrome	6.48e-05	0.000321	CcSEcCtD
Glimepiride—Dizziness—Felbamate—epilepsy syndrome	6.47e-05	0.000321	CcSEcCtD
Glimepiride—Dermatitis—Vigabatrin—epilepsy syndrome	6.47e-05	0.000321	CcSEcCtD
Glimepiride—ABCC8—Metabolism—PDXK—epilepsy syndrome	6.46e-05	0.000571	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ADK—epilepsy syndrome	6.46e-05	0.000571	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—L2HGDH—epilepsy syndrome	6.46e-05	0.000571	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GLUD1—epilepsy syndrome	6.46e-05	0.000571	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—FAR1—epilepsy syndrome	6.46e-05	0.000571	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CERS1—epilepsy syndrome	6.46e-05	0.000571	CbGpPWpGaD
Glimepiride—Pruritus—Oxcarbazepine—epilepsy syndrome	6.46e-05	0.00032	CcSEcCtD
Glimepiride—Convulsion—Pregabalin—epilepsy syndrome	6.45e-05	0.00032	CcSEcCtD
Glimepiride—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.45e-05	0.000319	CcSEcCtD
Glimepiride—Vision blurred—Gabapentin—epilepsy syndrome	6.44e-05	0.000319	CcSEcCtD
Glimepiride—Headache—Vigabatrin—epilepsy syndrome	6.44e-05	0.000319	CcSEcCtD
Glimepiride—Hypertension—Pregabalin—epilepsy syndrome	6.43e-05	0.000318	CcSEcCtD
Glimepiride—Vomiting—Diazepam—epilepsy syndrome	6.43e-05	0.000318	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	6.42e-05	0.000568	CbGpPWpGaD
Glimepiride—Anorexia—Valproic Acid—epilepsy syndrome	6.41e-05	0.000317	CcSEcCtD
Glimepiride—Tremor—Gabapentin—epilepsy syndrome	6.4e-05	0.000317	CcSEcCtD
Glimepiride—Rash—Diazepam—epilepsy syndrome	6.38e-05	0.000316	CcSEcCtD
Glimepiride—Dermatitis—Diazepam—epilepsy syndrome	6.37e-05	0.000316	CcSEcCtD
Glimepiride—Visual impairment—Topiramate—epilepsy syndrome	6.36e-05	0.000315	CcSEcCtD
Glimepiride—Dizziness—Zonisamide—epilepsy syndrome	6.34e-05	0.000314	CcSEcCtD
Glimepiride—Headache—Diazepam—epilepsy syndrome	6.34e-05	0.000314	CcSEcCtD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	6.33e-05	0.00056	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	6.33e-05	0.00056	CbGpPWpGaD
Glimepiride—Anxiety—Pregabalin—epilepsy syndrome	6.32e-05	0.000313	CcSEcCtD
Glimepiride—Diarrhoea—Clonazepam—epilepsy syndrome	6.32e-05	0.000313	CcSEcCtD
Glimepiride—Anaemia—Gabapentin—epilepsy syndrome	6.31e-05	0.000313	CcSEcCtD
Glimepiride—Hypotension—Valproic Acid—epilepsy syndrome	6.28e-05	0.000311	CcSEcCtD
Glimepiride—Asthenia—Carbamazepine—epilepsy syndrome	6.28e-05	0.000311	CcSEcCtD
Glimepiride—Agitation—Gabapentin—epilepsy syndrome	6.28e-05	0.000311	CcSEcCtD
Glimepiride—Diarrhoea—Phenytoin—epilepsy syndrome	6.28e-05	0.000311	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—L2HGDH—epilepsy syndrome	6.26e-05	0.000554	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CERS1—epilepsy syndrome	6.26e-05	0.000554	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GLUD1—epilepsy syndrome	6.26e-05	0.000554	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PDXK—epilepsy syndrome	6.26e-05	0.000554	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ADK—epilepsy syndrome	6.26e-05	0.000554	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—FAR1—epilepsy syndrome	6.26e-05	0.000554	CbGpPWpGaD
Glimepiride—Nausea—Fosphenytoin—epilepsy syndrome	6.26e-05	0.00031	CcSEcCtD
Glimepiride—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.24e-05	0.000309	CcSEcCtD
Glimepiride—Erythema multiforme—Topiramate—epilepsy syndrome	6.24e-05	0.000309	CcSEcCtD
Glimepiride—Angioedema—Gabapentin—epilepsy syndrome	6.24e-05	0.000309	CcSEcCtD
Glimepiride—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.23e-05	0.000309	CcSEcCtD
Glimepiride—Vomiting—Felbamate—epilepsy syndrome	6.22e-05	0.000308	CcSEcCtD
Glimepiride—Dry mouth—Pregabalin—epilepsy syndrome	6.2e-05	0.000307	CcSEcCtD
Glimepiride—Pruritus—Carbamazepine—epilepsy syndrome	6.19e-05	0.000307	CcSEcCtD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	6.19e-05	0.000548	CbGpPWpGaD
Glimepiride—Rash—Felbamate—epilepsy syndrome	6.17e-05	0.000306	CcSEcCtD
Glimepiride—Dermatitis—Felbamate—epilepsy syndrome	6.17e-05	0.000305	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	6.16e-05	0.000545	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	6.15e-05	0.000544	CbGpPWpGaD
Glimepiride—Headache—Felbamate—epilepsy syndrome	6.13e-05	0.000304	CcSEcCtD
Glimepiride—Confusional state—Pregabalin—epilepsy syndrome	6.13e-05	0.000304	CcSEcCtD
Glimepiride—Leukopenia—Gabapentin—epilepsy syndrome	6.11e-05	0.000303	CcSEcCtD
Glimepiride—Dizziness—Clonazepam—epilepsy syndrome	6.11e-05	0.000302	CcSEcCtD
Glimepiride—Nausea—Vigabatrin—epilepsy syndrome	6.1e-05	0.000302	CcSEcCtD
Glimepiride—Vomiting—Zonisamide—epilepsy syndrome	6.09e-05	0.000302	CcSEcCtD
Glimepiride—Insomnia—Valproic Acid—epilepsy syndrome	6.08e-05	0.000301	CcSEcCtD
Glimepiride—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.08e-05	0.000301	CcSEcCtD
Glimepiride—Asthenia—Lamotrigine—epilepsy syndrome	6.07e-05	0.000301	CcSEcCtD
Glimepiride—Dizziness—Phenytoin—epilepsy syndrome	6.07e-05	0.0003	CcSEcCtD
Glimepiride—Rash—Zonisamide—epilepsy syndrome	6.04e-05	0.000299	CcSEcCtD
Glimepiride—Paraesthesia—Valproic Acid—epilepsy syndrome	6.04e-05	0.000299	CcSEcCtD
Glimepiride—Palpitations—Gabapentin—epilepsy syndrome	6.04e-05	0.000299	CcSEcCtD
Glimepiride—Dermatitis—Zonisamide—epilepsy syndrome	6.04e-05	0.000299	CcSEcCtD
Glimepiride—Dizziness—Oxcarbazepine—epilepsy syndrome	6.03e-05	0.000299	CcSEcCtD
Glimepiride—Nausea—Diazepam—epilepsy syndrome	6.01e-05	0.000298	CcSEcCtD
Glimepiride—Loss of consciousness—Gabapentin—epilepsy syndrome	6e-05	0.000297	CcSEcCtD
Glimepiride—Headache—Zonisamide—epilepsy syndrome	6e-05	0.000297	CcSEcCtD
Glimepiride—Dyspnoea—Valproic Acid—epilepsy syndrome	5.99e-05	0.000297	CcSEcCtD
Glimepiride—Diarrhoea—Carbamazepine—epilepsy syndrome	5.99e-05	0.000297	CcSEcCtD
Glimepiride—Pruritus—Lamotrigine—epilepsy syndrome	5.99e-05	0.000297	CcSEcCtD
Glimepiride—Shock—Pregabalin—epilepsy syndrome	5.98e-05	0.000296	CcSEcCtD
Glimepiride—Somnolence—Valproic Acid—epilepsy syndrome	5.98e-05	0.000296	CcSEcCtD
Glimepiride—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.95e-05	0.000295	CcSEcCtD
Glimepiride—Tachycardia—Pregabalin—epilepsy syndrome	5.93e-05	0.000294	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	5.93e-05	0.000525	CbGpPWpGaD
Glimepiride—Dyspepsia—Valproic Acid—epilepsy syndrome	5.92e-05	0.000293	CcSEcCtD
Glimepiride—Convulsion—Gabapentin—epilepsy syndrome	5.92e-05	0.000293	CcSEcCtD
Glimepiride—ABCC8—Metabolism—EPM2A—epilepsy syndrome	5.91e-05	0.000523	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PNPO—epilepsy syndrome	5.91e-05	0.000523	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GAMT—epilepsy syndrome	5.91e-05	0.000523	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NHLRC1—epilepsy syndrome	5.91e-05	0.000523	CbGpPWpGaD
Glimepiride—Hypertension—Gabapentin—epilepsy syndrome	5.9e-05	0.000292	CcSEcCtD
Glimepiride—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.88e-05	0.000291	CcSEcCtD
Glimepiride—Vomiting—Clonazepam—epilepsy syndrome	5.87e-05	0.000291	CcSEcCtD
Glimepiride—Decreased appetite—Valproic Acid—epilepsy syndrome	5.85e-05	0.00029	CcSEcCtD
Glimepiride—Vomiting—Phenytoin—epilepsy syndrome	5.83e-05	0.000289	CcSEcCtD
Glimepiride—Rash—Clonazepam—epilepsy syndrome	5.82e-05	0.000288	CcSEcCtD
Glimepiride—Dermatitis—Clonazepam—epilepsy syndrome	5.82e-05	0.000288	CcSEcCtD
Glimepiride—Nausea—Felbamate—epilepsy syndrome	5.81e-05	0.000288	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.81e-05	0.000288	CcSEcCtD
Glimepiride—Vomiting—Oxcarbazepine—epilepsy syndrome	5.8e-05	0.000287	CcSEcCtD
Glimepiride—Fatigue—Valproic Acid—epilepsy syndrome	5.8e-05	0.000287	CcSEcCtD
Glimepiride—Anxiety—Gabapentin—epilepsy syndrome	5.79e-05	0.000287	CcSEcCtD
Glimepiride—Anorexia—Pregabalin—epilepsy syndrome	5.79e-05	0.000287	CcSEcCtD
Glimepiride—Dizziness—Carbamazepine—epilepsy syndrome	5.79e-05	0.000287	CcSEcCtD
Glimepiride—Diarrhoea—Lamotrigine—epilepsy syndrome	5.79e-05	0.000287	CcSEcCtD
Glimepiride—Headache—Clonazepam—epilepsy syndrome	5.78e-05	0.000287	CcSEcCtD
Glimepiride—Rash—Phenytoin—epilepsy syndrome	5.78e-05	0.000286	CcSEcCtD
Glimepiride—Dermatitis—Phenytoin—epilepsy syndrome	5.78e-05	0.000286	CcSEcCtD
Glimepiride—Rash—Oxcarbazepine—epilepsy syndrome	5.75e-05	0.000285	CcSEcCtD
Glimepiride—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.75e-05	0.000285	CcSEcCtD
Glimepiride—Headache—Phenytoin—epilepsy syndrome	5.75e-05	0.000285	CcSEcCtD
Glimepiride—Erythema—Topiramate—epilepsy syndrome	5.75e-05	0.000285	CcSEcCtD
Glimepiride—Malnutrition—Topiramate—epilepsy syndrome	5.75e-05	0.000285	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—PNPO—epilepsy syndrome	5.73e-05	0.000507	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GAMT—epilepsy syndrome	5.73e-05	0.000507	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NHLRC1—epilepsy syndrome	5.73e-05	0.000507	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—EPM2A—epilepsy syndrome	5.73e-05	0.000507	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	5.73e-05	0.000507	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	5.73e-05	0.000507	CbGpPWpGaD
Glimepiride—Headache—Oxcarbazepine—epilepsy syndrome	5.72e-05	0.000283	CcSEcCtD
Glimepiride—Nausea—Zonisamide—epilepsy syndrome	5.69e-05	0.000282	CcSEcCtD
Glimepiride—Dry mouth—Gabapentin—epilepsy syndrome	5.69e-05	0.000282	CcSEcCtD
Glimepiride—Hypotension—Pregabalin—epilepsy syndrome	5.68e-05	0.000281	CcSEcCtD
Glimepiride—Tension—Topiramate—epilepsy syndrome	5.64e-05	0.000279	CcSEcCtD
Glimepiride—Confusional state—Gabapentin—epilepsy syndrome	5.62e-05	0.000278	CcSEcCtD
Glimepiride—Dizziness—Lamotrigine—epilepsy syndrome	5.6e-05	0.000277	CcSEcCtD
Glimepiride—Nervousness—Topiramate—epilepsy syndrome	5.58e-05	0.000276	CcSEcCtD
Glimepiride—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.57e-05	0.000276	CcSEcCtD
Glimepiride—Vomiting—Carbamazepine—epilepsy syndrome	5.57e-05	0.000276	CcSEcCtD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	5.55e-05	0.000491	CbGpPWpGaD
Glimepiride—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.54e-05	0.000274	CcSEcCtD
Glimepiride—Rash—Carbamazepine—epilepsy syndrome	5.52e-05	0.000273	CcSEcCtD
Glimepiride—Dermatitis—Carbamazepine—epilepsy syndrome	5.52e-05	0.000273	CcSEcCtD
Glimepiride—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.5e-05	0.000272	CcSEcCtD
Glimepiride—Insomnia—Pregabalin—epilepsy syndrome	5.5e-05	0.000272	CcSEcCtD
Glimepiride—ABCC8—Metabolism—CA4—epilepsy syndrome	5.49e-05	0.000486	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—QDPR—epilepsy syndrome	5.49e-05	0.000486	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	5.49e-05	0.000486	CbGpPWpGaD
Glimepiride—Nausea—Clonazepam—epilepsy syndrome	5.49e-05	0.000272	CcSEcCtD
Glimepiride—Headache—Carbamazepine—epilepsy syndrome	5.48e-05	0.000272	CcSEcCtD
Glimepiride—Shock—Gabapentin—epilepsy syndrome	5.48e-05	0.000272	CcSEcCtD
Glimepiride—Paraesthesia—Pregabalin—epilepsy syndrome	5.46e-05	0.00027	CcSEcCtD
Glimepiride—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.46e-05	0.00027	CcSEcCtD
Glimepiride—Nausea—Phenytoin—epilepsy syndrome	5.45e-05	0.00027	CcSEcCtD
Glimepiride—Tachycardia—Gabapentin—epilepsy syndrome	5.44e-05	0.000269	CcSEcCtD
Glimepiride—Dyspnoea—Pregabalin—epilepsy syndrome	5.42e-05	0.000268	CcSEcCtD
Glimepiride—Nausea—Oxcarbazepine—epilepsy syndrome	5.42e-05	0.000268	CcSEcCtD
Glimepiride—Vision blurred—Topiramate—epilepsy syndrome	5.42e-05	0.000268	CcSEcCtD
Glimepiride—Somnolence—Pregabalin—epilepsy syndrome	5.4e-05	0.000268	CcSEcCtD
Glimepiride—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.39e-05	0.000267	CcSEcCtD
Glimepiride—Tremor—Topiramate—epilepsy syndrome	5.38e-05	0.000267	CcSEcCtD
Glimepiride—Vomiting—Lamotrigine—epilepsy syndrome	5.38e-05	0.000266	CcSEcCtD
Glimepiride—Urticaria—Valproic Acid—epilepsy syndrome	5.34e-05	0.000265	CcSEcCtD
Glimepiride—Rash—Lamotrigine—epilepsy syndrome	5.34e-05	0.000264	CcSEcCtD
Glimepiride—Dermatitis—Lamotrigine—epilepsy syndrome	5.33e-05	0.000264	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—QDPR—epilepsy syndrome	5.32e-05	0.000471	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CA4—epilepsy syndrome	5.32e-05	0.000471	CbGpPWpGaD
Glimepiride—Abdominal pain—Valproic Acid—epilepsy syndrome	5.32e-05	0.000263	CcSEcCtD
Glimepiride—Anorexia—Gabapentin—epilepsy syndrome	5.31e-05	0.000263	CcSEcCtD
Glimepiride—Anaemia—Topiramate—epilepsy syndrome	5.31e-05	0.000263	CcSEcCtD
Glimepiride—Headache—Lamotrigine—epilepsy syndrome	5.3e-05	0.000263	CcSEcCtD
Glimepiride—Decreased appetite—Pregabalin—epilepsy syndrome	5.28e-05	0.000262	CcSEcCtD
Glimepiride—Agitation—Topiramate—epilepsy syndrome	5.28e-05	0.000262	CcSEcCtD
Glimepiride—CYP2C9—Arachidonic acid metabolism—GPX1—epilepsy syndrome	5.26e-05	0.000465	CbGpPWpGaD
Glimepiride—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.25e-05	0.00026	CcSEcCtD
Glimepiride—Fatigue—Pregabalin—epilepsy syndrome	5.24e-05	0.00026	CcSEcCtD
Glimepiride—Hypotension—Gabapentin—epilepsy syndrome	5.21e-05	0.000258	CcSEcCtD
Glimepiride—Nausea—Carbamazepine—epilepsy syndrome	5.2e-05	0.000258	CcSEcCtD
Glimepiride—ABCC8—Metabolism—COX3—epilepsy syndrome	5.16e-05	0.000457	CbGpPWpGaD
Glimepiride—Leukopenia—Topiramate—epilepsy syndrome	5.14e-05	0.000255	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.1e-05	0.000452	CbGpPWpGaD
Glimepiride—Palpitations—Topiramate—epilepsy syndrome	5.08e-05	0.000252	CcSEcCtD
Glimepiride—Loss of consciousness—Topiramate—epilepsy syndrome	5.05e-05	0.00025	CcSEcCtD
Glimepiride—Insomnia—Gabapentin—epilepsy syndrome	5.04e-05	0.00025	CcSEcCtD
Glimepiride—Nausea—Lamotrigine—epilepsy syndrome	5.03e-05	0.000249	CcSEcCtD
Glimepiride—Feeling abnormal—Pregabalin—epilepsy syndrome	5.01e-05	0.000248	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—COX3—epilepsy syndrome	5.01e-05	0.000443	CbGpPWpGaD
Glimepiride—Paraesthesia—Gabapentin—epilepsy syndrome	5.01e-05	0.000248	CcSEcCtD
Glimepiride—Convulsion—Topiramate—epilepsy syndrome	4.98e-05	0.000247	CcSEcCtD
Glimepiride—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.97e-05	0.000246	CcSEcCtD
Glimepiride—Dyspnoea—Gabapentin—epilepsy syndrome	4.97e-05	0.000246	CcSEcCtD
Glimepiride—Hypertension—Topiramate—epilepsy syndrome	4.96e-05	0.000246	CcSEcCtD
Glimepiride—Somnolence—Gabapentin—epilepsy syndrome	4.96e-05	0.000245	CcSEcCtD
Glimepiride—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.95e-05	0.000245	CcSEcCtD
Glimepiride—Dyspepsia—Gabapentin—epilepsy syndrome	4.91e-05	0.000243	CcSEcCtD
Glimepiride—Glyburide—ALB—epilepsy syndrome	4.9e-05	0.00942	CrCbGaD
Glimepiride—ABCC8—Metabolism—KCNB1—epilepsy syndrome	4.89e-05	0.000433	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PFKL—epilepsy syndrome	4.89e-05	0.000433	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLCO1A2—epilepsy syndrome	4.89e-05	0.000433	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CACNA2D2—epilepsy syndrome	4.89e-05	0.000433	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC6A8—epilepsy syndrome	4.89e-05	0.000433	CbGpPWpGaD
Glimepiride—Anxiety—Topiramate—epilepsy syndrome	4.88e-05	0.000241	CcSEcCtD
Glimepiride—Decreased appetite—Gabapentin—epilepsy syndrome	4.85e-05	0.00024	CcSEcCtD
Glimepiride—Urticaria—Pregabalin—epilepsy syndrome	4.83e-05	0.000239	CcSEcCtD
Glimepiride—Asthenia—Valproic Acid—epilepsy syndrome	4.82e-05	0.000239	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.81e-05	0.000238	CcSEcCtD
Glimepiride—Fatigue—Gabapentin—epilepsy syndrome	4.81e-05	0.000238	CcSEcCtD
Glimepiride—Abdominal pain—Pregabalin—epilepsy syndrome	4.81e-05	0.000238	CcSEcCtD
Glimepiride—Dry mouth—Topiramate—epilepsy syndrome	4.78e-05	0.000237	CcSEcCtD
Glimepiride—Pruritus—Valproic Acid—epilepsy syndrome	4.76e-05	0.000236	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—CACNA2D2—epilepsy syndrome	4.75e-05	0.00042	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLCO1A2—epilepsy syndrome	4.75e-05	0.00042	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PFKL—epilepsy syndrome	4.75e-05	0.00042	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—KCNB1—epilepsy syndrome	4.75e-05	0.00042	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC6A8—epilepsy syndrome	4.75e-05	0.00042	CbGpPWpGaD
Glimepiride—Confusional state—Topiramate—epilepsy syndrome	4.73e-05	0.000234	CcSEcCtD
Glimepiride—Glyburide—ABCB1—epilepsy syndrome	4.67e-05	0.00899	CrCbGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	4.67e-05	0.000413	CbGpPWpGaD
Glimepiride—Shock—Topiramate—epilepsy syndrome	4.61e-05	0.000229	CcSEcCtD
Glimepiride—Diarrhoea—Valproic Acid—epilepsy syndrome	4.6e-05	0.000228	CcSEcCtD
Glimepiride—Feeling abnormal—Gabapentin—epilepsy syndrome	4.59e-05	0.000228	CcSEcCtD
Glimepiride—Thrombocytopenia—Topiramate—epilepsy syndrome	4.59e-05	0.000227	CcSEcCtD
Glimepiride—Tachycardia—Topiramate—epilepsy syndrome	4.58e-05	0.000227	CcSEcCtD
Glimepiride—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.56e-05	0.000226	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	4.55e-05	0.000403	CbGpPWpGaD
Glimepiride—Hyperhidrosis—Topiramate—epilepsy syndrome	4.53e-05	0.000225	CcSEcCtD
Glimepiride—Hypersensitivity—Pregabalin—epilepsy syndrome	4.48e-05	0.000222	CcSEcCtD
Glimepiride—ABCC8—Metabolism—ATIC—epilepsy syndrome	4.48e-05	0.000396	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NEU1—epilepsy syndrome	4.48e-05	0.000396	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—UPB1—epilepsy syndrome	4.48e-05	0.000396	CbGpPWpGaD
Glimepiride—Anorexia—Topiramate—epilepsy syndrome	4.47e-05	0.000221	CcSEcCtD
Glimepiride—Dizziness—Valproic Acid—epilepsy syndrome	4.45e-05	0.00022	CcSEcCtD
Glimepiride—Urticaria—Gabapentin—epilepsy syndrome	4.43e-05	0.000219	CcSEcCtD
Glimepiride—Abdominal pain—Gabapentin—epilepsy syndrome	4.41e-05	0.000218	CcSEcCtD
Glimepiride—Hypotension—Topiramate—epilepsy syndrome	4.38e-05	0.000217	CcSEcCtD
Glimepiride—Asthenia—Pregabalin—epilepsy syndrome	4.36e-05	0.000216	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—ATIC—epilepsy syndrome	4.34e-05	0.000384	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—UPB1—epilepsy syndrome	4.34e-05	0.000384	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NEU1—epilepsy syndrome	4.34e-05	0.000384	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HSD17B4—epilepsy syndrome	4.31e-05	0.000381	CbGpPWpGaD
Glimepiride—Pruritus—Pregabalin—epilepsy syndrome	4.3e-05	0.000213	CcSEcCtD
Glimepiride—Vomiting—Valproic Acid—epilepsy syndrome	4.28e-05	0.000212	CcSEcCtD
Glimepiride—Insomnia—Topiramate—epilepsy syndrome	4.24e-05	0.00021	CcSEcCtD
Glimepiride—Rash—Valproic Acid—epilepsy syndrome	4.24e-05	0.00021	CcSEcCtD
Glimepiride—Dermatitis—Valproic Acid—epilepsy syndrome	4.24e-05	0.00021	CcSEcCtD
Glimepiride—Headache—Valproic Acid—epilepsy syndrome	4.21e-05	0.000209	CcSEcCtD
Glimepiride—Paraesthesia—Topiramate—epilepsy syndrome	4.21e-05	0.000209	CcSEcCtD
Glimepiride—Dyspnoea—Topiramate—epilepsy syndrome	4.18e-05	0.000207	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—HSD17B4—epilepsy syndrome	4.18e-05	0.00037	CbGpPWpGaD
Glimepiride—Somnolence—Topiramate—epilepsy syndrome	4.17e-05	0.000206	CcSEcCtD
Glimepiride—ABCC8—Metabolism—PPP1R3C—epilepsy syndrome	4.16e-05	0.000368	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GBE1—epilepsy syndrome	4.16e-05	0.000368	CbGpPWpGaD
Glimepiride—Diarrhoea—Pregabalin—epilepsy syndrome	4.16e-05	0.000206	CcSEcCtD
Glimepiride—Dyspepsia—Topiramate—epilepsy syndrome	4.13e-05	0.000204	CcSEcCtD
Glimepiride—Hypersensitivity—Gabapentin—epilepsy syndrome	4.11e-05	0.000203	CcSEcCtD
Glimepiride—ABCC8—Neuronal System—PRKCB—epilepsy syndrome	4.08e-05	0.000361	CbGpPWpGaD
Glimepiride—Decreased appetite—Topiramate—epilepsy syndrome	4.08e-05	0.000202	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.05e-05	0.000201	CcSEcCtD
Glimepiride—Fatigue—Topiramate—epilepsy syndrome	4.04e-05	0.0002	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—GBE1—epilepsy syndrome	4.04e-05	0.000357	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPP1R3C—epilepsy syndrome	4.04e-05	0.000357	CbGpPWpGaD
Glimepiride—Dizziness—Pregabalin—epilepsy syndrome	4.02e-05	0.000199	CcSEcCtD
Glimepiride—Asthenia—Gabapentin—epilepsy syndrome	4e-05	0.000198	CcSEcCtD
Glimepiride—Nausea—Valproic Acid—epilepsy syndrome	3.99e-05	0.000198	CcSEcCtD
Glimepiride—KCNJ11—Neuronal System—PRKCB—epilepsy syndrome	3.96e-05	0.00035	CbGpPWpGaD
Glimepiride—Pruritus—Gabapentin—epilepsy syndrome	3.94e-05	0.000195	CcSEcCtD
Glimepiride—ABCC8—Metabolism—ASAH1—epilepsy syndrome	3.91e-05	0.000346	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.87e-05	0.000342	CbGpPWpGaD
Glimepiride—Vomiting—Pregabalin—epilepsy syndrome	3.87e-05	0.000191	CcSEcCtD
Glimepiride—Feeling abnormal—Topiramate—epilepsy syndrome	3.86e-05	0.000191	CcSEcCtD
Glimepiride—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.83e-05	0.00019	CcSEcCtD
Glimepiride—Rash—Pregabalin—epilepsy syndrome	3.83e-05	0.00019	CcSEcCtD
Glimepiride—Dermatitis—Pregabalin—epilepsy syndrome	3.83e-05	0.00019	CcSEcCtD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	3.83e-05	0.000339	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	3.83e-05	0.000339	CbGpPWpGaD
Glimepiride—Diarrhoea—Gabapentin—epilepsy syndrome	3.81e-05	0.000189	CcSEcCtD
Glimepiride—Headache—Pregabalin—epilepsy syndrome	3.81e-05	0.000189	CcSEcCtD
Glimepiride—ABCC8—Metabolism—STXBP1—epilepsy syndrome	3.81e-05	0.000337	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ASAH1—epilepsy syndrome	3.79e-05	0.000336	CbGpPWpGaD
Glimepiride—Urticaria—Topiramate—epilepsy syndrome	3.73e-05	0.000185	CcSEcCtD
Glimepiride—ABCC8—Metabolism—NT5E—epilepsy syndrome	3.71e-05	0.000328	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALAD—epilepsy syndrome	3.71e-05	0.000328	CbGpPWpGaD
Glimepiride—Abdominal pain—Topiramate—epilepsy syndrome	3.71e-05	0.000184	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—STXBP1—epilepsy syndrome	3.69e-05	0.000327	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.69e-05	0.000326	CbGpPWpGaD
Glimepiride—Dizziness—Gabapentin—epilepsy syndrome	3.69e-05	0.000183	CcSEcCtD
Glimepiride—Nausea—Pregabalin—epilepsy syndrome	3.61e-05	0.000179	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—NT5E—epilepsy syndrome	3.6e-05	0.000318	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALAD—epilepsy syndrome	3.6e-05	0.000318	CbGpPWpGaD
Glimepiride—Vomiting—Gabapentin—epilepsy syndrome	3.54e-05	0.000176	CcSEcCtD
Glimepiride—ABCC8—Metabolism—ALDH7A1—epilepsy syndrome	3.54e-05	0.000313	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CACNA1A—epilepsy syndrome	3.54e-05	0.000313	CbGpPWpGaD
Glimepiride—Rash—Gabapentin—epilepsy syndrome	3.51e-05	0.000174	CcSEcCtD
Glimepiride—Dermatitis—Gabapentin—epilepsy syndrome	3.51e-05	0.000174	CcSEcCtD
Glimepiride—Headache—Gabapentin—epilepsy syndrome	3.49e-05	0.000173	CcSEcCtD
Glimepiride—ABCC8—Metabolism—ST3GAL3—epilepsy syndrome	3.46e-05	0.000306	CbGpPWpGaD
Glimepiride—Hypersensitivity—Topiramate—epilepsy syndrome	3.46e-05	0.000171	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—ALDH7A1—epilepsy syndrome	3.43e-05	0.000304	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CACNA1A—epilepsy syndrome	3.43e-05	0.000304	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ADSL—epilepsy syndrome	3.39e-05	0.0003	CbGpPWpGaD
Glimepiride—Asthenia—Topiramate—epilepsy syndrome	3.36e-05	0.000167	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—ST3GAL3—epilepsy syndrome	3.36e-05	0.000297	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.35e-05	0.000297	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GLUL—epilepsy syndrome	3.33e-05	0.000294	CbGpPWpGaD
Glimepiride—Pruritus—Topiramate—epilepsy syndrome	3.32e-05	0.000164	CcSEcCtD
Glimepiride—Nausea—Gabapentin—epilepsy syndrome	3.31e-05	0.000164	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—ADSL—epilepsy syndrome	3.29e-05	0.000291	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP2C19—epilepsy syndrome	3.29e-05	0.000291	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP11A1—epilepsy syndrome	3.27e-05	0.000289	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CACNA1D—epilepsy syndrome	3.27e-05	0.000289	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.24e-05	0.000287	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GLUL—epilepsy syndrome	3.23e-05	0.000285	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.22e-05	0.000285	CbGpPWpGaD
Glimepiride—Diarrhoea—Topiramate—epilepsy syndrome	3.21e-05	0.000159	CcSEcCtD
Glimepiride—KCNJ11—Metabolism—CACNA1D—epilepsy syndrome	3.17e-05	0.00028	CbGpPWpGaD
Glimepiride—Dizziness—Topiramate—epilepsy syndrome	3.1e-05	0.000154	CcSEcCtD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	3.1e-05	0.000274	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TXNRD1—epilepsy syndrome	3.05e-05	0.00027	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.03e-05	0.000269	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.01e-05	0.000266	CbGpPWpGaD
Glimepiride—Vomiting—Topiramate—epilepsy syndrome	2.98e-05	0.000148	CcSEcCtD
Glimepiride—ABCC8—Metabolism—AQP1—epilepsy syndrome	2.97e-05	0.000262	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TXNRD1—epilepsy syndrome	2.96e-05	0.000262	CbGpPWpGaD
Glimepiride—Rash—Topiramate—epilepsy syndrome	2.96e-05	0.000146	CcSEcCtD
Glimepiride—Dermatitis—Topiramate—epilepsy syndrome	2.95e-05	0.000146	CcSEcCtD
Glimepiride—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	2.95e-05	0.000261	CbGpPWpGaD
Glimepiride—Headache—Topiramate—epilepsy syndrome	2.94e-05	0.000146	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.91e-05	0.000258	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.91e-05	0.000257	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.9e-05	0.000257	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AQP1—epilepsy syndrome	2.88e-05	0.000254	CbGpPWpGaD
Glimepiride—Nausea—Topiramate—epilepsy syndrome	2.79e-05	0.000138	CcSEcCtD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.72e-05	0.000241	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—KCNJ11—epilepsy syndrome	2.68e-05	0.000237	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CHRM3—epilepsy syndrome	2.68e-05	0.000237	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.65e-05	0.000235	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CHRM3—epilepsy syndrome	2.6e-05	0.00023	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.55e-05	0.000226	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.32e-05	0.000205	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CA13—epilepsy syndrome	2.25e-05	0.000199	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCG2—epilepsy syndrome	2.19e-05	0.000193	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP2C19—epilepsy syndrome	2.13e-05	0.000189	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCG2—epilepsy syndrome	2.12e-05	0.000188	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP11A1—epilepsy syndrome	2.12e-05	0.000187	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP2C19—epilepsy syndrome	2.07e-05	0.000183	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP11A1—epilepsy syndrome	2.05e-05	0.000182	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP2D6—epilepsy syndrome	1.91e-05	0.000169	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP2D6—epilepsy syndrome	1.85e-05	0.000164	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.82e-05	0.000161	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ADRA2A—epilepsy syndrome	1.82e-05	0.000161	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—BCHE—epilepsy syndrome	1.81e-05	0.00016	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.81e-05	0.00016	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ADRA2A—epilepsy syndrome	1.76e-05	0.000156	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—BCHE—epilepsy syndrome	1.76e-05	0.000155	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC2A1—epilepsy syndrome	1.73e-05	0.000153	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLCB1—epilepsy syndrome	1.71e-05	0.000151	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.7e-05	0.000151	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.7e-05	0.000151	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.7e-05	0.000151	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.7e-05	0.000151	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.7e-05	0.000151	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.7e-05	0.000151	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TH—epilepsy syndrome	1.7e-05	0.000151	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC2A1—epilepsy syndrome	1.68e-05	0.000148	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLCB1—epilepsy syndrome	1.66e-05	0.000147	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TH—epilepsy syndrome	1.65e-05	0.000146	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.56e-05	0.000138	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.56e-05	0.000138	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.56e-05	0.000138	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.56e-05	0.000138	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.45e-05	0.000128	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.45e-05	0.000128	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.44e-05	0.000128	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMOX1—epilepsy syndrome	1.42e-05	0.000126	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CAT—epilepsy syndrome	1.4e-05	0.000124	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMOX1—epilepsy syndrome	1.38e-05	0.000122	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCB1—epilepsy syndrome	1.36e-05	0.000121	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.36e-05	0.000121	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CAT—epilepsy syndrome	1.36e-05	0.00012	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCB1—epilepsy syndrome	1.32e-05	0.000117	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.29e-05	0.000114	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.29e-05	0.000114	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.29e-05	0.000114	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.29e-05	0.000114	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.29e-05	0.000114	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GPX1—epilepsy syndrome	1.27e-05	0.000112	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.26e-05	0.000112	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.25e-05	0.000111	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GPX1—epilepsy syndrome	1.23e-05	0.000109	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.18e-05	0.000105	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.18e-05	0.000105	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.18e-05	0.000105	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.14e-05	0.000101	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AGT—epilepsy syndrome	1.11e-05	9.84e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.1e-05	9.72e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.1e-05	9.72e-05	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOE—epilepsy syndrome	1.09e-05	9.64e-05	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AGT—epilepsy syndrome	1.08e-05	9.54e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.07e-05	9.5e-05	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOE—epilepsy syndrome	1.06e-05	9.35e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.03e-05	9.14e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1e-05	8.89e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NT5E—epilepsy syndrome	9.79e-06	8.66e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALAD—epilepsy syndrome	9.79e-06	8.66e-05	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—POMC—epilepsy syndrome	9.36e-06	8.28e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	9.34e-06	8.26e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	9.34e-06	8.26e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	9.14e-06	8.09e-05	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—POMC—epilepsy syndrome	9.08e-06	8.03e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ADSL—epilepsy syndrome	8.95e-06	7.92e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GLUL—epilepsy syndrome	8.78e-06	7.77e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	8.62e-06	7.63e-05	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALB—epilepsy syndrome	8.54e-06	7.55e-05	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALB—epilepsy syndrome	8.28e-06	7.32e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	8.06e-06	7.13e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AQP1—epilepsy syndrome	7.83e-06	6.93e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.52e-06	6.65e-05	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS2—epilepsy syndrome	7.47e-06	6.61e-05	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS2—epilepsy syndrome	7.24e-06	6.41e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	7.08e-06	6.26e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	7.08e-06	6.26e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.59e-06	5.83e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.46e-06	5.71e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	5.77e-06	5.11e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	5.62e-06	4.98e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	5.59e-06	4.94e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.55e-06	4.91e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.06e-06	4.48e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	5.04e-06	4.46e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	4.8e-06	4.25e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—BCHE—epilepsy syndrome	4.78e-06	4.23e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	4.56e-06	4.04e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	4.51e-06	3.99e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TH—epilepsy syndrome	4.49e-06	3.98e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.43e-06	3.92e-05	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKT1—epilepsy syndrome	3.75e-06	3.32e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.75e-06	3.32e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.7e-06	3.28e-05	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKT1—epilepsy syndrome	3.64e-06	3.22e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.6e-06	3.19e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.35e-06	2.96e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.94e-06	2.6e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.88e-06	2.55e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.47e-06	2.19e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.25e-06	1.99e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.97e-06	1.74e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKT1—epilepsy syndrome	9.9e-07	8.76e-06	CbGpPWpGaD
